About Robert Goforth
Form D filings for Solaris Vaccines from 2022 to 2023 list Robert Goforth as director.
Robert Goforth first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Robert Goforth in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Robert Goforth works with at each company, as listed on that company's latest Form D.
Solaris Vaccines, Inc. · Form D, May 19, 2023
MA
Michael Artinger
CEO and director